Resmonics
Zürich, Switzerland
Resmonics’ mission is to develop disease self-management solutions for chronic respiratory diseases that are truly compatible with patients’ everyday lives. By offering our solutions to other companies for integration into their already existing products, we empower them to deliver a completely new and highly attractive value proposition to their end users (patients). Our first product, Asthma Guardian, turns a patient’s smartphone into a guardian angel at night that protects them from life-threatening disease escalations (such as asthma attacks). The technology behind Asthma Guardian, namely deep learning based digital biomarkers, has been developed and clinically validated in five years of research at leading Swiss universities and healthcare providers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.resmonics.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Resmonics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now